CEO and Co-Founder
InSphero AG, Switzerland
SLAS and InSphero share a long history: both were founded around the same time, and we have participated at every SLAS International Conference and Exhibition since the very first in 2012. Every time, it was a fantastic opportunity to meet like-minded scientists, key opinion leaders, customers and partners to drive laboratory science further.
After nearly ten years, during which my organization has enjoyed the opportunities that SLAS has offered, I am eager to contribute to its strategic growth as a Board Member. As a microfluidics engineer working on 3D cell-based, automated in-vitro assays I can embrace many of the scientific facets of SLAS and its diverse and unique member base. As a startup entrepreneur, I want to be an advocate for startups and SMEs – two groups which are immensely relevant to our ecosystem. Their presence on the exhibition floor is invaluable for attendees seeking novel technologies as part of their SLAS experience.
Finally, based in the center of Europe I can support the expansion of SLAS into the region and can help fine tune the strategy for this culturally diverse part of the world. In the coming years, I see three key opportunities for SLAS to push the limits of laboratory science, grow as an organization and provide added value to its members: 1) expanding into machine learning and artificial intelligence for drug discovery and safety harnessing the vast amount of data from high-content imaging and -omics technologies; 2) the continuation of digital meetings and short courses, including hybrid conferences with on-site attendees and exhibitors and online access; 3) the continued expansion into key Asia markets in close collaboration with local organizations.
As an SLAS Board Member I will work openly and diligently to support SLAS’ development assuring scientific and educational relevance, attractivity for members, as well as sustainable financing.